Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03145181. IPD Sharing: Not stated. Countries: 5. Publications: 13.
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
ClinicalTrials.gov study NCT04133636. IPD Sharing: YES. Countries: 8. Publications: 1.
Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elde
ClinicalTrials.gov study NCT04751877. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT03651128. IPD Sharing: Not stated. Countries: 13. Publications: 4.
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
ClinicalTrials.gov study NCT03751293. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00821249. IPD Sharing: YES. Countries: 1. Publications: 1.
Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04537442. IPD Sharing: NO. Countries: 1. Publications: 2.
Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma
ClinicalTrials.gov study NCT05536700. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
ClinicalTrials.gov study NCT01421524. IPD Sharing: Not stated. Countries: 5. Publications: 3.
A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05236621. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent Therapy
ClinicalTrials.gov study NCT01023880. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Matched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCT
ClinicalTrials.gov study NCT00599495. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients
ClinicalTrials.gov study NCT01554852. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00934154. IPD Sharing: Not stated. Countries: 1. Publications: 1.
D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma
ClinicalTrials.gov study NCT00083876. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00044018. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
ClinicalTrials.gov study NCT05956457. IPD Sharing: NO. Countries: 1. Publications: 30.
A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT03374085. IPD Sharing: YES. Countries: 11. Publications: 1.
A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma
ClinicalTrials.gov study NCT06717113. IPD Sharing: YES. Countries: 1. Publications: 3.
Quality of Life the Danish Multiple Myeloma Patients
ClinicalTrials.gov study NCT02892383. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.